Image 1 (Image 01)
Duloxetine Capsule, Delayed Release
Product Images NDC 71335-1964
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71335-1964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2 (Image 02)
This is a graph showing the proportion of patients with relapse over time from randomization to relapse in days for the treatment with Duloxetine and Placebo. The X-axis represents time, and the Y-axis represents the proportion of patients. The graph shows that the proportion of patients with relapse is lower for the Duloxetine treatment compared to the Placebo treatment over time.*
Image 3 (Image 03)
Image 4 (Image 04)
Image 5 (Image 05)
Image 6 (Image 06)
This is a chart that shows the percentage of patients improved in terms of pain reduction after taking different doses of Duloxetine, a medication used to treat depression and anxiety. The chart displays the percent improvement in pain from the baseline, with the highest dose of 120mg showing the most improvement (-9%), followed by 60mg (-8%), and 20mg showing no improvement (0%). The chart also includes a placebo, indicated by "XXX", which shows no improvement.*
Image 7 (Image 07)
The text represents a chart showing the percentage of patients who improved after taking Duloxetine 60/120 mg Once Daily compared to a Placebo. The percentage of improvement ranges from 0% to 100%, with the drug showing an 8% improvement above the placebo. The chart also includes a percent improvement in pain from the baseline, but specific values are not given.*
Image 8 (Image 08)
The text provides a graph showing the percentage of patients who improved when treated with Duloxetine 60 mg once daily compared to a placebo. The graph also displays the percent improvement in pain from baseline. No further information is available to provide additional context or details.*
Image 9 (Image 09)
The text provides a graph showing the percentage of patients that improved using placebo and Duloxetine 60/120 mg once daily, and the percent improvement in pain from baseline. The graph also includes numbers from 210 to 290.*
Label (Lbl713351964)
This appears to be packaging information for a medication called Cymbalta 20mg Capsule produced by Zhejiang Huahai Pharma Co., Ltd. The package was prepackaged by Bryant Ranck Prepack and comes in a pack of 30 capsules with an expiration date of MM/YY. The medication may cause drowsiness and should be stored at room temperature between 20°-25°C (68°-77°F). The last line appears to be a potentially unreliable identification number, as it contains non-English characters.*
Chemical Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
